Mustang Bio financials
$0.4796−5.39%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — | — |
| Operating income | -$2.4M | -$16.2M | -$50.7M | -$76.2M | -$66.7M | -$56.8M | -$45.9M | -$31.2M | -$31.8M |
| Net income | -$1.9M | -$15.8M | -$51.6M | -$77.5M | -$66.4M | -$60.0M | -$46.4M | -$30.7M | -$31.3M |
| Net margin | — | — | — | — | — | — | — | — | — |
| Diluted EPS | $-0.39 | $-25.84 | $-299.95 | $-504.50 | $-570.00 | $-855.00 | $-967.50 | $-855.00 | $-930.00 |
| EBITDA | -$2.4M | -$11.9M | -$48.3M | -$71.7M | -$58.6M | -$45.0M | -$38.2M | -$27.2M | -$31.8M |
| Operating cash flow | -$5.3M | -$11.4M | -$49.5M | -$65.1M | -$53.7M | -$37.3M | -$33.6M | -$19.2M | -$12.9M |
| Free cash flow | -$5.3M | -$11.4M | -$49.5M | -$67.8M | -$57.7M | -$39.2M | -$35.9M | -$26.1M | -$13.4M |
| Diluted shares | 4.9M | 0.6M | 0.2M | 0.2M | 0.1M | 0.1M | 0.0M | 0.0M | 0.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $17.3M | $6.8M | $6.2M | $75.7M | $109.6M | $97.8M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $0.00 | $0.00 | $0.00 | $27.4M | $0.00 | $0.00 |
| Total assets | $17.6M | $9.3M | $17.7M | $92.4M | $125.2M | $109.9M |
| Total liabilities | $8.1M | $13.2M | $17.6M | $46.1M | $12.8M | $11.5M |
| Shareholders' equity | $9.5M | -$3.9M | $123.0K | $46.3M | $112.4M | $98.4M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology